Evidence map›Paper›PMID 34848712›Full record

ArticleNature communications2021

Neuropilin 1 regulates bone marrow vascular regeneration and hematopoietic reconstitution.

Christina M Termini, Amara Pang, Tiancheng Fang, Martina Roos, Vivian Y Chang, Yurun Zhang, Nicollette J Setiawan, Lia Signaevskaia, Michelle Li, Mindy M Kim and 7 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Sema3A Affect Osteolytic Bone Metastasis of Non-small Cell Lung Cancer.Recent patents on anti-cancer drug discovery · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Christina M TerminiDivision of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-1831-1347
Amara PangDivision of Hematology & Cellular Therapy, Cedars Sinai Medical Center, Los Angeles, CA, USA.
Tiancheng FangDivision of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, CA, USA.
Martina RoosDivision of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, CA, USA.
Vivian Y ChangJonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, USA.
Yurun ZhangDivision of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, CA, USA.
Nicollette J SetiawanDivision of Hematology & Cellular Therapy, Cedars Sinai Medical Center, Los Angeles, CA, USA.
Lia SignaevskaiaDivision of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, CA, USA.
Michelle LiDivision of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, CA, USA.
Mindy M KimDivision of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, CA, USA.
Orel TabibiDivision of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, CA, USA.
Paulina K LinDivision of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, CA, USA.
Joshua P SasineDivision of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-9866-462X
Avradip ChatterjeeDepartment of Biomedical Sciences, Research Division of Immunology, Los Angeles, USA.
Ramachandran MuraliDepartment of Biomedical Sciences, Research Division of Immunology, Los Angeles, USA.
Heather A HimburgDepartment of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
John P ChuteDivision of Hematology & Cellular Therapy, Cedars Sinai Medical Center, Los Angeles, CA, USA. john.chute@cshs.org.
University of California, Los Angeles · USCedars-Sinai Medical Center · USMedical College of Wisconsin · USUCLA Health · US

Funding

UCLA Center for Biological RadioprotectorsU19AI067769 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MCBRIDE, WILLIAM H. · 2005 to 2019
$44.6M
Semaphorin signaling regulates vascular and hematopoietic regenerationR01HL086998 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHUTE, JOHN P · 2008 to 2022
$4.6M
Dkk1-Endothelial Progenitor Cell Treatment for the Mitigation of Hematopoietic Radiation InjuryU01AI138331 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HIMBURG, HEATHER A · 2018 to 2022
$3.0M
Decoupling Bidirectional EphB/ephrinB2 in Multiple MyelomaK08CA245483 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SASINE, JOSHUA P · 2020 to 2024
$1.3M
Regulation of Stem Cell Aging and Cancer by the Vascular NicheK08HL138305 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHANG, VIVIAN Y-J · 2017 to 2021
$891k
The role of Syndecan-2 in hematopoietic stem cell maintenance and regenerationK01DK126989 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TERMINI, CHRISTINA MARIE · 2021 to 2025
$719k
NCI NIH HHS K08 CA245483NHLBI NIH HHS K08 HL138305NHLBI NIH HHS R01 HL086998NIAID NIH HHS U01 AI138331NIAID NIH HHS U19 AI067769NIDDK NIH HHS K01 DK126989
6 · The paper itself

Abstract

Ionizing radiation and chemotherapy deplete hematopoietic stem cells and damage the vascular niche wherein hematopoietic stem cells reside. Hematopoietic stem cell regeneration requires signaling from an intact bone marrow (BM) vascular niche, but the mechanisms that control BM vascular niche regeneration are poorly understood. We report that BM vascular endothelial cells secrete semaphorin 3 A (SEMA3A) in response to myeloablation and SEMA3A induces p53 - mediated apoptosis in BM endothelial cells via signaling through its receptor, Neuropilin 1 (NRP1), and activation of cyclin dependent kinase 5. Endothelial cell - specific deletion of Nrp1 or Sema3a or administration of anti-NRP1 antibody suppresses BM endothelial cell apoptosis, accelerates BM vascular regeneration and concordantly drives hematopoietic reconstitution in irradiated mice. In response to NRP1 inhibition, BM endothelial cells increase expression and secretion of the Wnt signal amplifying protein, R spondin 2. Systemic administration of anti - R spondin 2 blocks HSC regeneration and hematopoietic reconstitution which otherwise occurrs in response to NRP1 inhibition. SEMA3A - NRP1 signaling promotes BM vascular regression following myelosuppression and therapeutic blockade of SEMA3A - NRP1 signaling in BM endothelial cells accelerates vascular and hematopoietic regeneration in vivo.

Indexed as

AnimalsApoptosisBone MarrowBone Marrow CellsCyclin-Dependent Kinase 5FemaleHematopoietic Stem CellsMaleMiceMice, Inbred C57BLNeuropilin-1RegenerationSemaphorin-3ASignal TransductionTranscriptomeWnt ProteinsCdk5 protein, mouseCyclin-Dependent Kinase 5Neuropilin-1Sema3a protein, mouseSemaphorin-3AWnt Proteins

Identifiers

PMID34848712
PMCPMC8635308
OpenAlexW3216810308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.